Construction of Youshi Plant I completed and officially operational.
Passed Canadian CMDCAS certification for Canadian market entry.
Groundbreaking for Youshi Plant II.
Introduced automated production equipment; Youshi Plant II officially operational.
Awarded Golden Peak Awards for "Top 10 Outstanding Enterprises" and "Top 10 Outstanding R&D Innovations."
Received the "D&B SME Elite Award."
Awarded the 18th "Rising Star Award."
Awarded the "National Biotechnology and Medical Care Quality Award."
Completed the IDB (MOEA) Biotechnology Project: Anti-adhesion Coating Development for Bipolar Electrosurgical Forceps Tips.
Approved for the SBIR Project: Research and Development of Multi-purpose Suction Irrigation Tubing for Laparoscopic Surgery.
Won the Taipei Biotech Award - "International Innovation Excellence Award."
Awarded the 25th "National Award of Outstanding SMEs."
Won the Taichung Golden Hand Award.
Passed Malaysia MDA approval and obtained Malaysian sales clearance.
Passed Singapore HSA approval and obtained Singaporean sales clearance.
Completed quality system transition to ISO 13485:2016.
Filed for initial public offering (IPO) with the TPEx, effective January 16, 2019.
Obtained CE Certificate from BSI.
Passed Serbia ALIMS approval for sales clearance in Serbia.
Completed NT$11,000 thousand cash capital increase by issuing 1,100,000 shares, bringing paid-in capital to NT$304,769 thousand.
LAGIS stock officially registered on the Emerging Stock Market.
Obtained Korean approval for Electrosurgical Suction & Irrigation Systems.
Youshi Plant II obtained Factory Registration Certificate and Medical Device Manufacturer License.
Trocar, SI-450CT, and SI-450C obtained sales clearance in Singapore.
Adopted solar power generation to promote energy conservation and carbon reduction.
Re-evaluated the new facility project for Youshi Plant II and approved by the MOEA "Action Plan for Welcoming Taiwanese Businesses to Invest in Taiwan."
EBH-0709 and EB-0709 obtained sales clearance in Malaysia.
Implemented Material Flow Cost Accounting (MFCA) system.
Trocar obtained BSI Class IIa MDR Certificate.
Began redevelopment and reconstruction of Youshi Plant II.
TR, TRO, and TRE obtained sales clearance in Albania.
EB, EBH, and SI obtained sales clearance in Brazil.
Completed transition of MDD product certificates to MDR certificates.
Certified for ISO 14001 Environmental Management System.
Implemented Greenhouse Gas (GHG) inventory program.
Balloon Trocar (TRS) obtained sales clearance in Taiwan.
Inflation Device (IP) obtained UK market clearance.
Electrosurgical Suction Irrigation System (SAP) obtained market clearance in Thailand.
Suction Irrigation Tube (SA) and Endoscopic Instruments (DI, EI) obtained market clearance in Australia.
Veress Needle (IN), Suction Irrigation Tube (SA), Endoscopic Instruments (DI, EI), and Wound Retractor (WR) obtained clearance in El Salvador.
Trocar (TR) obtained sales clearance in Israel and Bahrain.
Wound Retractor (WR) and Cap (CP) obtained market clearance in Ecuador.
Obtained MDSAP certification.
Youshi Plant II obtained Usage Permit.
Dajia Plant II obtained Factory Registration Certificate.
Dajia Plant II obtained Medical Device Manufacturer License.
Dajia Plant II passed Taiwan QMS audit.
Published the company's first ESG Sustainability Report.
Stock officially listed and traded on the Taipei Exchange (TPEx Mainboard).
